1-20 of 24
Di Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Daratumumab in Light Chain Amyloidosis: A Single-Center Retrospective Study

Xinran Wang, Ning An, Qiuxia Yu, Yuhan Bao, Peiling Zhang, Wei Mu, Chunrui Li, Di Wang, Xiaolu Long
Journal: Blood
Blood (2024) 144 (Supplement 1): 7833.
https://doi.org/10.1182/blood-2024-204637
Published: 2024
Journal Articles

A Phase I Study of a Novel BCMA×CD3 Bispecific Antibody Emb-06 in Relapsed or Refractory Multiple Myeloma

Peter Tan, LI Bao, Qingsong Yin, Chunrui Li, Sorab Jehangir Shavaksha, H. Miles Prince, Zhen Cai, SHAN GAO, Qian Wang, Di Wang, YI LI, Mingfei Zhang, Qiumei Deng, Qiaoyang Lu, Chengjun Jiang, Fang Ren, Danqing Wu, Shuqi Zeng, Yonghong Zhu, Yi Tao, Yuanfang Liu, Jian-Qing Mi
Journal: Blood
Blood (2024) 144 (Supplement 1): 498.
https://doi.org/10.1182/blood-2024-193738
Published: 2024
Journal Articles

Selinexor in Combination with Standard or Reduced-Dose Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Multiple Myeloma

Su Shuai, Bin Xu, Chunrui Li, Di Wang, Xiwen Tong, Yi Zhu, Xia Mao, Min Xiao, Donghua Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 7062.
https://doi.org/10.1182/blood-2024-204278
Published: 2024
Journal Articles

Predictive Model for Infection Risk in CAR-T Therapy Patients

Ning An, Chunrui Li, Hui Luo, Xinran Wang, Di Wang, Peiling Zhang, Wei Mu, Qiuxia Yu, Yuhan Bao, Yang Gao
Journal: Blood
Blood (2024) 144 (Supplement 1): 7211.
https://doi.org/10.1182/blood-2024-204477
Published: 2024
Journal Articles

Comparative Effectiveness of Linvoseltamab Versus Current Real-World (RW) Standard-of-Care (SOC) Therapies in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma (RRMM): Key Subgroups Analysis

Shaji Kumar, Sundar Jagannath, Katja C. Weisel, Laura Rosiñol Dachs, Meletios-Athanasios Dimopoulos, David S. Siegel, Jorge Monge, Xavier Leleu, Juan Du, Javier de la Rubia, Jae Hoon Lee, María-Victoria Mateos, Borja Puertas Martínez, Alessandro Gozzetti, Dominik Dytfeld, Enrique M. Ocio, Joan Bladé, Shuji Ozaki, Meral Beksac, Fernando Escalante, Madhu Nagaraj, Rafla Hassan, Paul Spin, Nicolle Bonar, Mostafa Shokoohi, Muhaimen Siddiqui, Di Wang, Kevin Hou, Jeannette Green, Olivier Humblet, Alexander Breskin, James Harnett, Wenzhen Ge, Rachel E. Sobel, Jessica J. Jalbert, Glenn S. Kroog, Karen Rodriguez Lorenc, Qiufei Ma, Christian Hampp, Brian G.M. Durie
Journal: Blood
Blood (2024) 144 (Supplement 1): 7012.
https://doi.org/10.1182/blood-2024-200679
Published: 2024
Journal Articles

Impact of CAR T-Cell Persistence on Clinical Outcomes in Relapsed/Refractory Multiple Myeloma: Insights from the Phase 2 Fumanba-1 Study

Chunrui Li, Dehui Zou, Di Wang, Baijun Fang, He Huang, Jianyong Li, Bing Chen, Jing Liu, Xi Zhang, Yujun Dong, Kai Hu, Peng Liu, Jianqing Mi, Kaiyang Ding, Zhenyu Li, Qie Dong, Fuyuan Zhang, Guang Hu, Lu-Gui Qiu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4761.
https://doi.org/10.1182/blood-2024-204355
Published: 2024
Journal Articles

Preliminary Data on the Efficacy and Safety of Orelabrutinib Combined with Rituximab and Methotrexate (ORM Regimen) As First-Line Treatment for Primary Central Nervous System Lymphoma, and the Exploration of Cerebrospinal Fluid Ctdna Dynamic Monitoring

Lixia Sheng, Guifang Ouyang, Yanli Lai, Sheng Nie, Di Wang, Shanhao Tang, Yuning Pan, Kaihong Xu, Yongcheng Sun, Ping Zhang, Binbin Lai, Lieguang Chen
Journal: Blood
Blood (2024) 144 (Supplement 1): 4500.
https://doi.org/10.1182/blood-2024-198355
Published: 2024
Journal Articles

Efficacy Outcomes and Characteristics of Patients with Multiple Myeloma (MM) Who Achieved Sustained Minimal Residual Disease Negativity after Treatment with Equecabtagene Autoleucel (Eque-cel, CT103A) in Fumanba-1

Chunrui Li, Lu-Gui Qiu, Di Wang, Yongping Song, He Huang, Jianyong Li, Bing Chen, Jing Liu, Yujun Dong, Kai Hu, Peng Liu, Xi Zhang, Jianqing Mi, Zhenyu Li, Kaiyang Ding, Shiyue Zhang, Guang Hu, Wen Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 761.
https://doi.org/10.1182/blood-2023-173427
Published: 2023
Journal Articles

Long-Term Follow-up of Fully Human BCMA-Targeting CAR (CT103A) in Patients with Relapsed/Refractory Multiple Myeloma

Chunrui Li, Di Wang, Qiuxia Yu, Zhe Li, Wen Wang, Guang Hu, Wei Mu, Chunhui Li, Ning An, Xiaolu Long, Yuhan Bao
Journal: Blood
Blood (2023) 142 (Supplement 1): 4854.
https://doi.org/10.1182/blood-2023-181394
Published: 2023
Journal Articles

Patterns of CS1 Expression on Natural Killer Cells and Correlated Factors in Plasma Cell Dyscrasias

Chunrui Li, Di Wang, Chunhui Li, Yanjie Xu, Xia Mao, Yimei Que, Zhe Li, Qiuxia Yu, Ning An, Xiaolu Long
Journal: Blood
Blood (2023) 142 (Supplement 1): 6686.
https://doi.org/10.1182/blood-2023-184537
Published: 2023
Journal Articles

Ksd-101 in Patients with EBV-Associated Hematologic Neoplasms: Results from an Ongoing Phase I Clinical Study

Chunrui Li, Di Wang, Atsuhiko Hasegawa, Huining Liu, Ning An, Yuhan Bao, Meijuan Huang, Yi Xiao, Donghua Zhang, Miao Zheng, Wei Huang, Lijun Jiang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4837.
https://doi.org/10.1182/blood-2023-182556
Published: 2023
Journal Articles

Updated Results of Fumanba-1: A Phase 1b/2 Study of a Novel Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT103A) in Patients with Relapsed and/or Refractory Multiple Myeloma

Chunrui Li, Di Wang, Baijun Fang, Yongping Song, He Huang, Jianyong Li, Dehui Zou, Bing Chen, Jing Liu, Yujun Dong, Hanyun Ren, Kai Hu, Peng Liu, Xi Zhang, Jian-Qing Mi, Zhenyu Li, Kaiyang Ding, Jue Wang, Liting Chen, Aining Xu, Songbai Cai, Jingwen Zeng, Jingjing Guo, Hongyu Gui, Wen Wang, Lugui Qiu
Journal: Blood
Blood (2022) 140 (Supplement 1): 7435–7436.
https://doi.org/10.1182/blood-2022-166465
Published: 2022
Journal Articles

A Phase 1/2 Study of a Novel Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT103A) in Patients with Relapsed and/or Refractory Multiple Myeloma

Chunrui Li, Di Wang, Yongping Song, Jianyong Li, He Huang, Bing Chen, Jing Liu, Kai Hu, Hanyun Ren, Xi Zhang, Zhenyu Li, Dehui Zou, Qingsong Yin, Lijuan Chen, Yongxian HU, Yong Xu, Qian Cheng, Yuelu Guo, Yujun Dong, Li Gao, Aining Xu, Songbai Cai, Wen Wang, Ming Wu, Jue Wang, Liting Chen, Jianfeng Zhou, Lugui Qiu
Journal: Blood
Blood (2021) 138 (Supplement 1): 547.
https://doi.org/10.1182/blood-2021-152576
Published: 2021
Journal Articles

A phase 1 study of a novel fully human BCMA-targeting CAR (CT103A) in patients with relapsed/refractory multiple myeloma

Clinical Trials & Observations
Di Wang, Jue Wang, Guang Hu, Wen Wang, Yi Xiao, Haodong Cai, Lijun Jiang, Li Meng, Yongkun Yang, Xiaoxi Zhou, Zhenya Hong, Zheng Yao, Min Xiao, Liting Chen, Xia Mao, Li Zhu, Jin Wang, Lugui Qiu, Chunrui Li, Jianfeng Zhou
Journal: Blood
Blood (2021) 137 (21): 2890–2901.
https://doi.org/10.1182/blood.2020008936
Published: 2021
Includes: Supplemental data
Journal Articles

Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies

Clinical Trials & Observations
Na Wang, Xuelian Hu, Wenyue Cao, Chunrui Li, Yi Xiao, Yang Cao, Chaojiang Gu, Shangkun Zhang, Liting Chen, Jiali Cheng, Gaoxiang Wang, Xiaoxi Zhou, Miao Zheng, Xia Mao, Lijun Jiang, Di Wang, Qiuxiang Wang, Yaoyao Lou, Haodong Cai, Dandan Yan, Yicheng Zhang, Tongcun Zhang, Jianfeng Zhou, Liang Huang
Journal: Blood
Blood (2020) 135 (1): 17–27.
https://doi.org/10.1182/blood.2019000017
Published: 2020
Includes: Supplemental data
Journal Articles

Persistent Red Blood Cell (RBC) Transfusion Is Associated with Increased Mortality Risk in Transfusion-Dependent (TD) Patients with Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS+)

Rena Buckstein, MD FRCPC, Nancy Zhu, MD, Mary-Margaret Keating, MD, Brian Leber, MD, Lisa Chodirker, MD, Mitchell Sabloff, Grace Cristou, Heather A. Leitch, MD, Eve St. Hilaire, Nicholas Finn, MD, Karen W.L. Yee, MD, Mohamed Elemary, MD, Versha Banerji, MD, Martha Lenis, Aksharh Kirubananthaan, Fei Fei Liu, Derek Tang, PhD BSPharm, Chris Westcott, Vicky Wei-Hsuen Huang, Di Wang, Chris Cameron, Jessica Morison, Paul Spin, Alexandre Mamedov
Journal: Blood
Blood (2019) 134 (Supplement_1): 3012.
https://doi.org/10.1182/blood-2019-123684
Published: 2019
Journal Articles

Efficacy and Safety of Fully Human Bcma Targeting CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma

Chunrui Li, MD PhD, Jue Wang, MD PhD, Di Wang, MD PhD, Guang Hu, Yongkun Yang, Xiaoxi Zhou, MD PhD, Li Meng, MD PhD, Zhenya Hong, MD PhD, Liting Chen, PhD, Xia Mao, MD PhD, Min Xiao, MD PhD, Jianfeng Zhou, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 929.
https://doi.org/10.1182/blood-2019-128468
Published: 2019
Journal Articles

Effective Chimeric Antigen Receptor T Cell Therapy for Relapsed and Refractory Acute Lymphoblastic Leukemia in Children Can be Administered Safely Under the Real-Time Monitoring of Th1/Th2 Cytokine Patterns Measured By the Cytometric Bead Array Technology

Yongmin Tang, MD, Diying Shen, MD, Lei Xiao, PhD, Hua Song, MD, Fenying Zhao, MD, Xiaojun Xu, MD, Weiqun Xu, MD PhD, Di Wang, MD, Juan Liang, MD, Meixin Fang, MD, Chan Liao, MD PhD, Sisi Li, MD PhD, Ning Zhao, MS, Wei Huang, MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4030.
https://doi.org/10.1182/blood-2018-99-120007
Published: 2018
Journal Articles

Heterogeneous Responses Among Ph + -B-ALLs to Imatinib with NRAS Mutant Being One Mechanism of Complete Resistance

Xiaoyu An, Jinping Liu, Na Wang, MD PhD, Di Wang, MD PhD, Liang Huang, MD PhD, Jie Cai, PhD, Demin Zhou, PhD, Henry Li, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5801.
https://doi.org/10.1182/blood-2018-99-115516
Published: 2018
Journal Articles

Anti-CD30 Chimeric Antigen Receptor T Cell Therapy for CD30 + Relapsed/Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients

Di Wang, MD PhD, Yi Xiao, MD PhD, Chunrui Li, MDPhD, Na Wang, MD PhD, Liang Huang, MDPhD, Yicheng Zhang, MDPhD, Tongcun Zhang, PhD, Jianfeng Zhou, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1660.
https://doi.org/10.1182/blood-2018-99-116741
Published: 2018